Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 3, 2010
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
Elizabeth S Gabitzsch, Younong Xu, Joseph P Balint, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
December 21, 2006
Mapping resistance to Southern rust in a tropical by temperate maize recombinant inbred topcross population
M P Jines, P Balint-Kurti, L A Robertson-Hoyt, et al.
Cancer Gene Therapy
|
September 5, 2015
An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
A E Rice, Y E Latchman, J P Balint, et al.
Journal of Immunological Methods
|
August 3, 1987
Selective removal of antigen-complexed IgG from cat plasma by adsorption onto a protein A-silica matrix
H W Snyder, N R Ernst, L S Grosmaire, et al.
Cancer Research
|
November 1, 1987
Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma
A K Singhal, M C Singhal, E Nudelman, et al.
Blood
|
May 11, 1992
Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura
H W Snyder, S K Cochran, J P Balint, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 11, 2014
Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease
Antoinette J Pusateri, Sandra C Kim, Jennifer L Dotson, et al.
Seminars in Arthritis and Rheumatism
|
September 17, 2019
Comorbidity clusters in generalized osteoarthritis among female patients: A cross-sectional study
E Kovari, A Kaposi, G Bekes, et al.
Cancer Immunology, Immunotherapy : CII
|
May 10, 2015
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Joseph P Balint, Elizabeth S Gabitzsch, Adrian Rice, et al.
Vaccine
|
October 9, 2012
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform
Elizabeth S Gabitzsch, Joseph P Balint-Junior, Younong Xu, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Cancer Immunology, Immunotherapy : CII
|
April 3, 2010
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
Elizabeth S Gabitzsch, Younong Xu, Joseph P Balint, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
December 21, 2006
Mapping resistance to Southern rust in a tropical by temperate maize recombinant inbred topcross population
M P Jines, P Balint-Kurti, L A Robertson-Hoyt, et al.
Cancer Gene Therapy
|
September 5, 2015
An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
A E Rice, Y E Latchman, J P Balint, et al.
Journal of Immunological Methods
|
August 3, 1987
Selective removal of antigen-complexed IgG from cat plasma by adsorption onto a protein A-silica matrix
H W Snyder, N R Ernst, L S Grosmaire, et al.
Cancer Research
|
November 1, 1987
Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma
A K Singhal, M C Singhal, E Nudelman, et al.
Blood
|
May 11, 1992
Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura
H W Snyder, S K Cochran, J P Balint, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 11, 2014
Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease
Antoinette J Pusateri, Sandra C Kim, Jennifer L Dotson, et al.
Seminars in Arthritis and Rheumatism
|
September 17, 2019
Comorbidity clusters in generalized osteoarthritis among female patients: A cross-sectional study
E Kovari, A Kaposi, G Bekes, et al.
Cancer Immunology, Immunotherapy : CII
|
May 10, 2015
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Joseph P Balint, Elizabeth S Gabitzsch, Adrian Rice, et al.
Vaccine
|
October 9, 2012
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform
Elizabeth S Gabitzsch, Joseph P Balint-Junior, Younong Xu, et al.
Page
of 6